Bill Burns is the former president, CEO and board member of Encore Vision Inc., which he sold to Novartis in January 2017 for $375 million in upfront payments plus undisclosed future milestone payments. Currently, Bill serves on boards and as a consultant for other health care companies in the eye care and cancer therapeutics fields.

Before his time at Encore Vision, Bill spent 20 years at Alcon Laboratories, holding several executive positions, including vice president of worldwide marketing for pharmaceutical and consumer products. In this role, he was responsible for strategic marketing direction and input to clinical product development. Bill also held the position of director of business development at Bristol Myers Squibb and worked at Norwich-Eaton Laboratories.

Bill has a bachelor’s degree in biology and biochemistry from Slippery Rock University and is a graduate of Harvard Business School’s Program for Management Development.